跳至主要内容
临床试验/ACTRN12613001129774
ACTRN12613001129774已完成4 期

Study on the Clinical Outcomes of Piperacillin-Tazobactam Extended 4-hour Infusion as compared to Piperacillin-Tazobactam Traditional 30-minute Infusion in Patients Hospitalised for a Bacterial Infection or Neutropenic Fever - A Prospective Clinical Trial

Fan Sheung Yin0 个研究点目标入组 360 人开始时间: 2013年10月10日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients were eligible if they were aged 18 years or older; were hospitalized in an acute medical unit or intensive care unit; either had received a diagnosis of bacterial infection or suffered from neutropenic fever; planned to receive treatment of Piperacillin-Tazobactam for at least 48 hours.

排除标准

  • Patients would be excluded if they are pregnant, had received more than 48 hours of effective antibiotics, as defined by specimen culture sensitivity results, within five days of initiation of extended 4-hour infusion or traditional 30-minute infusions of Piperacillin-Tazobactam; had been receiving other beta-lactam antibiotics concomitantly.

研究者

发起方
Fan Sheung Yin

相似试验